Previous 10 | Next 10 |
BioLife Solutions to Report Second Quarter 2021 Financial Results and Provide Business Update on August 12, 2021 PR Newswire BOTHELL, Wash. , Aug. 5, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS) ("BioLife" or the "Company"), a leading ...
The CPI-W increased 6.1% year-over-year in June. Healthcare is historically a strong performer later in the business cycle. The healthcare sector is improving in our large cap sector ranking. Top scoring healthcare stocks worth adding to your watch list. For further deta...
BioLife Solutions Announces Changes to Board of Directors Chairman of the Board Raymond W. Cohen Retires After 15 Years of Service CEO Mike Rice Elected Chairman PR Newswire BOTHELL, Wash. , July 14, 2021 /PRNewswire/ -- BioLife Solutions , ...
BioLife Solutions, Inc. is a developer, manufacturer, and marketer of bioproduction tools and services for the cell and gene therapy industry. BioLife Solutions currently operates one bioproduction tools and services business with various product lines that support the stages of biolo...
There is a growing prominence in the cell and gene-based therapy sector. Logistic providers of the aforesaid sector are enjoying huge revenue surges. As a premier company, BioLife is garnering robust top-line growth through organic expansion and external acquisitions. With the rec...
BioLife Solutions Adopts New Brand Identity PR Newswire BOTHELL, Wash. , June 15, 2021 /PRNewswire/ -- BioLife Solutions , Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"), a leading developer and supplier of class-defining bioproduction prod...
Image source: The Motley Fool. Biolife Solutions Inc (NASDAQ: BLFS) Q1 2021 Earnings Call May 13, 2021 , 4:30 p.m. ET Operator Continue reading For further details see: Biolife Solutions Inc (BLFS) Q1 2021 Earnings Call Transcript
BioLife Solutions, Inc. (BLFS) Q1 2021 Earnings Conference Call May 13, 2021, 16:30 PM ET Company Participants Rod de Greef - Chief Financial Officer Mike Rice - Chief Executive Officer Dusty Tenney - President and Chief Operating Officer Conference Call Participants Chris Lin - Cowen Jacob J...
BioLife Solutions (BLFS): Q1 Non-GAAP EPS of $0.01 beats by $0.01; GAAP EPS of -$0.03 beats by $0.01.Revenue of $16.85M (+38.6% Y/Y) beats by $0.8M.Full year revenue guidance raised to $106 to $115 million vs. $105.65M reflecting confidence in outlookPress Release For further details ...
BioLife Solutions Announces First Quarter 2021 Financial Results Achieves record quarterly revenue of $16.8 million, a 39% increase over the prior year and 14% increase over the prior quarter Full year revenue guidance raised to $106 to $115 million reflecting confidence in ...
News, Short Squeeze, Breakout and More Instantly...
BioLife Solutions Inc. Company Name:
BLFS Stock Symbol:
NASDAQ Market:
BioLife Solutions Inc. Website:
BioLife Solutions to Report Second Quarter 2024 Financial Results and Business Update on August 8, 2024 PR Newswire BOTHELL, Wash. , July 25, 2024 /PRNewswire/ -- BioLife Solutions , Inc. (NASDAQ: BLFS), a leading supplier of class-defining bioproduction...
BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouver BioLife Solutions Introduces the CellSeal CryoCase™ at International Society for Cell & Gene Therapies (ISCT) Conference in Vancouv...
BioLife Solutions Reports First Quarter 2024 Financial Results PR Newswire Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38% and net loss of $10.2 million Non-GAAP adjusted gross margin expands ...